Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hESC-derived MSC-like cells for meniscus injury
NCT03839238Phase 1Unknown
- Sponsor
- Tongji Hospital
- Start
- Jan 2019
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in meniscus injury, sponsored by Tongji Hospital. Primary endpoint: Adverse Events at 3 months. Status: unknown.
02
Conditions
meniscus injury
Beyond the preview
Go deeper on NCT03839238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03839238.